Therapeutic Uses
Antiretroviral / Anti-HIV
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
N-[[P(S),2′R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine 1-(methyl-d3)ethyl-2,2,2-d3 ester
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Sofosbuvir-d6 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Sofosbuvir-d6 usage and description
Sofosbuvir D6 is a deuterated analog of Sofosbuvir, a direct-acting antiviral drug used to treat hepatitis C virus (HCV) infection. The deuterium substitution provides improved pharmacokinetic properties, allowing for better absorption and distribution of the drug in the body. Sofosbuvir D6 works by inhibiting the RNA polymerase enzyme, which is essential for HCV replication, thus preventing the virus from reproducing and spreading in the body.
Sofosbuvir D6 is typically administered orally in the form of a tablet, with a recommended dosage of 400mg per day. The drug is commonly used in combination with other antiviral medications, such as ledipasvir or velpatasvir, to increase its effectiveness in treating HCV infection. Sofosbuvir D6 has been shown to have a high cure rate for HCV, with minimal side effects.
Chemically, Sofosbuvir D6 is a prodrug that is metabolized in the liver to its active form, GS-461203. The drug is primarily eliminated through the kidneys, and its half-life in the body is approximately 0.5 to 2 hours. Sofosbuvir D6 is a white to off-white powder that is soluble in water and ethanol.
In conclusion, Sofosbuvir D6 is an effective and safe medication used to treat HCV infection. Its deuterated structure provides improved pharmacokinetic properties, allowing for better absorption and distribution in the body. When used in combination with other antiviral medications, Sofosbuvir D6 has a high cure rate for HCV, making it an important tool in the fight against this disease.
